Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H26O6S |
| Molecular Weight | 382.471 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CCC(=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])C(=O)C=C4C[C@H](CC[C@]34C)OS(O)(=O)=O
InChI
InChIKey=LOQLFQHJYJBJRP-GINZOMEDSA-N
InChI=1S/C19H26O6S/c1-18-7-5-12(25-26(22,23)24)9-11(18)10-15(20)17-13-3-4-16(21)19(13,2)8-6-14(17)18/h10,12-14,17H,3-9H2,1-2H3,(H,22,23,24)/t12-,13-,14-,17-,18-,19-/m0/s1
| Molecular Formula | C19H26O6S |
| Molecular Weight | 382.471 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:48:53 GMT 2023
by
admin
on
Sat Dec 16 11:48:53 GMT 2023
|
| Record UNII |
KDZ5JN125F
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
54044549
Created by
admin on Sat Dec 16 11:48:53 GMT 2023 , Edited by admin on Sat Dec 16 11:48:53 GMT 2023
|
PRIMARY | |||
|
4121-96-4
Created by
admin on Sat Dec 16 11:48:53 GMT 2023 , Edited by admin on Sat Dec 16 11:48:53 GMT 2023
|
PRIMARY | |||
|
KDZ5JN125F
Created by
admin on Sat Dec 16 11:48:53 GMT 2023 , Edited by admin on Sat Dec 16 11:48:53 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> METABOLITE |
Plasma concentrations 12 hours after the 3.beta.-acetyl-7-oxo-DHEA dose at 7 and 28 days on the 200 mg/d dose were 15.8 and 16.3 mcg/L respectively (n=16).
IN-VIVO
PLASMA
|
